Outlook Therapeutics, Inc. OTLK
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2016-06-13
Outlook Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 663,496 | $4.9M |
| RENAISSANCE TECHNOLOGIES LLC | 255,157 | $52,511 |
| CITADEL ADVISORS LLC | 194,500 | $40,028 |
| Point72 Asset Management, L.P. | 29,038 | $5,976 |
Source: SEC EDGAR filings · CIK 0001649989 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.